This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire Lille (Chu), Institut Pasteur De Lille, Medizinische Hochschule Hannover. Active years: 2020.
Company Filing History:
1 out of 1 
1 out of 65 
1 out of 87 
Years Active: 2020
Title: Pascal De Groote: Innovator in Cardiac Health
Introduction
Pascal De Groote is a notable inventor based in Lille, France. He has made significant contributions to the field of cardiac health through his innovative research and patents. His work focuses on predicting disease progression in heart failure and myocardial infarction patients.
Latest Patents
Pascal De Groote holds a patent titled "Mitochondrial non-coding RNAs for predicting disease progression in heart failure and myocardial infarction patients." This invention relates to a method for predicting mortality in patients with chronic heart failure by detecting the expression levels of specific long non-coding RNAs (lncRNAs). Additionally, it provides a method for predicting cardiac remodeling after myocardial infarction based on the same lncRNAs.
Career Highlights
Throughout his career, Pascal has worked with esteemed institutions such as Medizinische Hochschule Hannover and the Institut National De La Santé Et De La Recherche Médicale. His research has been pivotal in advancing the understanding of cardiac health and improving patient outcomes.
Collaborations
Pascal has collaborated with notable colleagues, including Thomas Thum and Regalla Kumarswamy. Their joint efforts have contributed to the development of innovative solutions in the medical field.
Conclusion
Pascal De Groote's work exemplifies the impact of innovation in healthcare, particularly in the realm of cardiac disease prediction. His contributions continue to influence the medical community and improve patient care.